None listed
Conditions
Brief summary
X-linked retinoschisis is a genetic eye disorder characterised by abnormal splitting of the retina, resulting in a loss of vision. Currently there is no treatment available for X-linked retinoschisis. However, an improvement in sight has been reported following the use of topical and oral acetazolamide in people with X-linked retinoschisis. Hence, the objective of this study is to investigate whether oral acetazolamide improves the sight of people with X-linked retinoschisis.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
- Patients with X-linked retinoschisis diagnosis and stable ocular fixation with no clinically significant media opacities. There will be no age restrictions
Exclusion criteria
- Hypersensitivity to sulphonamides and sulphonamide derivatives - Women who are pregnant - People in existing dependent or unequal relationships - People highly dependent on medical care - Aboriginal and/or Torres Striait Islander People - People who may be involved in illegal activity - People with an intellectual or mental impairment - People whose primary language is other than English. - A refractive error greater than ±6 diopters (D) sphere - Uveitis - Optic neuropathy - The presence of nystagmus or any other retinal diseases affecting the macula other than retinoschisis - A recent history (<6months) of intraocular surgery, and poor optical coherent tomography (OCT) image quality.